Meeting
2016 ASCO Annual Meeting
PD-L1, B7-H3, and PD-1 expression in immunocompetent versus immunosuppressed patients with advanced cutaneous squamous carcinoma (cSCC).
Authors
Vinod Varki
University of Maryland Medical Center. Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD
Vinod Varki , Olga B. Ioffe , Soren Bentzen , Ashley L Cellini , Josephine Louella Feliciano , Dan Paul Zandberg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Biologic Correlates
Citation
J Clin Oncol 34, 2016 (suppl; abstr 9576)
DOI
10.1200/JCO.2016.34.15_suppl.9576
Abstract #
9576
Poster Bd #
181
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
The immune impact of PI3K-AKT pathway inhibition in colorectal cancer.
First Author: Maliha Nusrat
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Clinical significance of PD-L1 levels in plasma-derived exosomes in head and neck cancer.
First Author: Marie-Nicole Theodoraki
Poster
2017 ASCO Annual Meeting
Prognostic impact of PD-1, PD-L1, and CD8 genes expression in peripheral blood in gastric cancer.
First Author: Shuhei Ito
Poster
2017 Genitourinary Cancers Symposium
Impact of immune checkpoint protein expression in tumor cells and tumor infiltrating CD8+ T cells on clinical benefit from PD-1 blockade in metastatic clear cell renal cell carcinoma (mccRCC).
First Author: Jean-Christophe Pignon